P.450 A phase I single-rising-dose study of oral BI 1358894 in healthy male volunteers: safety, pharmacokinetics and food effect

2020 ◽  
Vol 40 ◽  
pp. S256-S257
Author(s):  
R. Fuertig ◽  
M. Goettel ◽  
J. Höfler ◽  
V. Sharma
Keyword(s):  
Phase I ◽  
Food Effect ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Dose Study

scholarly journals A first‐in‐human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers

2021 ◽  
Vol 9 (3) ◽  
Author(s):  
Folke Sjöberg ◽  
Susanna Waters ◽  
Boel Löfberg ◽  
Clas Sonesson ◽  
Nicholas Waters ◽  
...  
Keyword(s):  
Oral Dose ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Dose Study

Multiple Rising Doses of Oral BI 1358894 in Healthy Male Volunteers: A Phase I Study to Investigate Safety and Tolerability

2020 ◽  
Vol 87 (9) ◽  
pp. S417-S418
Author(s):  
Markus Goettel ◽  
Lena Herich ◽  
Sabrina Wiebe ◽  
Rene Fuertig ◽  
Vikas Sharma ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers

A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers

2012 ◽  
Vol 50 (12) ◽  
pp. 896-906 ◽  
Author(s):  
Gustavo D. Mendes ◽  
Hilton Oliveira dos Santos Filho ◽  
Alberto dos Santos Pereira ◽  
Fabiana D. Mendes ◽  
Jaime O. Ilha ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase I ◽  
Pde5 Inhibitor ◽  
Phase I Clinical Trial ◽  
Healthy Male ◽  
Healthy Male Volunteers ◽  
Male Volunteers ◽  
Phosphodiesterase Type
Sign in / Sign up

Export Citation Format

Share Document